Baxter International Inc

BAX.US
Healthcare · Medical Instruments & Supplies
24.37
+1.03 (+4.41%)
USD · NYSE

Company Information

Company Name
Baxter International Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: US0718131099
CIK: 0000010456
CUSIP: 071813141
Currency: USD
Full Time Employees: 37,500
Phone: 224 948 2000
Fiscal Year End: December
IPO Date: Oct 27, 1981
Description:

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Address:

One Baxter Parkway, Deerfield, IL, United States, 60015

People

Directors & Officers

Name Title Year Born
Mr. Andrew P. Hider CEO, President, Interim Group President of Medical Products & Therapies and Director 1977
Mr. David S. Rosenbloom Executive VP & General Counsel 1960
Ms. Maria Soriano Group President of Infusion Therapies & Platforms NA
Ms. Anita A. Zielinski Interim CFO, Senior VP, Chief Accounting Officer & Controller 1973
Mr. Charles Rusty Patel Senior VP & Chief Information Officer 1970
Mr. Kevin Moran Vice President & Head of Investor Relations NA
Ms. Stacey Eisen SVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation NA
Ms. Cynthia Carlisle Executive VP & Chief Human Resources Officer 1976
Mr. James W. Borzi Executive VP & Chief Supply Chain Officer 1963
Mr. Steven P. Wallace President of Advanced Surgery & Commercial Excellence 1981

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 17, 2026 Michael T. McCaul N/A Purchase N/A $20.74 N/A
Feb 17, 2026 Ro Khanna N/A Purchase N/A $20.74 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $19.74 N/A
Jan 13, 2026 Michael T. McCaul N/A Purchase N/A $19.66 N/A
Nov 10, 2025 Ro Khanna N/A Sale N/A $17.75 N/A
Oct 31, 2025 Lisa C. McClain N/A Sale N/A $18.47 N/A
Oct 30, 2025 Lisa C. McClain N/A Sale N/A $19.17 N/A
Oct 30, 2025 Lisa C. McClain N/A Purchase N/A $19.17 N/A
Sep 29, 2025 Ro Khanna N/A Purchase N/A $22.36 N/A
Sep 25, 2025 Lisa C. McClain N/A Purchase N/A $21.75 N/A
Sep 05, 2025 Ro Khanna N/A Sale N/A $24.42 N/A
Sep 03, 2025 Ro Khanna N/A Sale N/A $23.52 N/A
Aug 26, 2025 Ro Khanna N/A Purchase N/A $24.55 N/A
Aug 12, 2025 Ro Khanna N/A Sale N/A $23.95 N/A
Aug 04, 2025 Lisa C. McClain N/A Sale N/A $22.41 N/A
Aug 04, 2025 Ro Khanna N/A Purchase N/A $22.41 N/A
Jul 22, 2025 Lisa C. McClain N/A Purchase N/A $27.53 N/A
Jun 26, 2025 Ro Khanna N/A Sale N/A $30.53 N/A
Jun 23, 2025 Ro Khanna N/A Sale N/A $30.01 N/A
Jun 16, 2025 Ro Khanna N/A Sale N/A $30.80 N/A

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 79.40M Mar 31, 2026 15.37% $0.02 -6.35%
Pzena Investment Management, LLC 64.53M Mar 31, 2026 12.49% $3.52 -7.88%
Vanguard Group Inc 62.64M Dec 31, 2025 12.13% $0.02 0.18%
Dodge & Cox 57.25M Mar 31, 2026 11.09% $0.53 0.45%
FMR Inc 46.26M Mar 31, 2026 8.96% $0.04 32.90%
Vanguard Capital Management, LLC 33.51M Mar 31, 2026 6.49% $0.01 0.00%
Vanguard Portfolio Management, LLC 23.99M Mar 31, 2026 4.65% $0.02 0.00%
State Street Corp 19.98M Mar 31, 2026 3.87% $0.01 -11.35%
Greenhaven Associates Inc 14.31M Mar 31, 2026 2.77% $3.96 33.80%
Geode Capital Management, LLC 13.76M Mar 31, 2026 2.66% $0.01 1.87%
Amvescap Plc. 13.12M Mar 31, 2026 2.54% $0.02 10.62%
Morgan Stanley - Brokerage Accounts 7.35M Mar 31, 2026 1.42% $0.01 -14.72%
First Pacific Advisors, LP 6.70M Mar 31, 2026 1.30% $1.58 0.00%
Equity Investment Corp 6.37M Mar 31, 2026 1.23% $2.10 30.09%
State Farm Mutual Automobile Ins Co 6.23M Mar 31, 2026 1.21% $0.08 0.00%
NORGES BANK 6.19M Dec 31, 2025 1.20% $0.01 13.21%
Bank of America Corp 6.17M Mar 31, 2026 1.19% $0.01 44.29%
Dimensional Fund Advisors, Inc. 5.93M Mar 31, 2026 1.15% $0.02 2.79%
Charles Schwab Investment Management Inc 5.59M Mar 31, 2026 1.08% $0.01 5.23%
Artisan Partners Limited Partnership 4.86M Mar 31, 2026 0.94% $0.13 2.18%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Dodge & Cox Stock I 38.62M 7.48% ▲ 0.00% Jun 30, 2026
2 BlackRock Equity Dividend Instl 19.53M 3.78% ▼ 1.01% Jun 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 16.40M 3.18% ▼ 0.08% Jun 30, 2026
4 Vanguard 500 Index Investor 13.42M 2.60% ▼ 0.36% Jun 30, 2026
5 Vanguard Small Cap Index 11.84M 2.29% ▲ 0.03% Jun 30, 2026
6 Pzena Large Cap Value 10.44M 2.02% ▲ 0.00% Jun 30, 2026
7 Vanguard Windsor Investor Shares 10.44M 2.02% ▲ 0.00% Mar 31, 2026
8 Fidelity Series Large Cap Stock 8.97M 1.74% ▲ 13.92% May 31, 2026
9 Invesco S&P 500® Equal Weight ETF 8.96M 1.74% ▲ 0.31% Jun 30, 2026
10 Vanguard Small Cap Value Index Inv 7.52M 1.46% ▼ 1.44% Jun 30, 2026

Financial Highlights

Market Cap: $12.05B
EBITDA: $1.91B
PEG Ratio: $36.68
Book Value: $11.70
Dividend/Share: $0.36
Dividend Yield: 1.61%
Earnings/Share: $-1.91
Profit Margin: -9.70%
Operating Margin: 6.03%
ROA (TTM): 2.85%
ROE (TTM): -15.01%
Revenue (TTM): $11.32B
Revenue/Share (TTM): $22.03
Earnings Growth (YOY): 237.90%
Revenue Growth (YOY): 2.90%

Valuation Metrics

Enterprise Value: $19.24B
Trailing P/E: 0.00
Forward P/E: 11.79

Shares Statistics

Shares Outstanding: 516.47M
Shares Float: 513.98M
% Insiders: 33.90%
% Institutions: 10,612.40%
Short % Float: 11.26%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$11.24B
Cost of Goods Sold
adjust
$-7.87B
Gross Profit
subtotal
$3.38B
SG&A
adjust
$-2.89B
R&D
adjust
$-518.00M
Other Operating Expense
adjust
$-279.00M
Operating Income
subtotal
$-308.00M
Other / Non-Operating Items
adjust
$-649.00M
Net Income
subtotal
$-957.00M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BAX.US!